MIR6806

Across TCGA pan-cancer cohorts, MIR6806 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MIR6806 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher MIR6806 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6806 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CHOL show a favorable association.

READ, COAD, and LGG are the cancer types where MIR6806 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.105	0.824	<.001	99	view →
COAD	DFS	Tertile	II,III,IV	0.393	0.674	.003	96	view →
LGG	DFS	Tertile	All	0.748	0.865	<.001	38	view →
STAD	DFS	Tertile	III,IV	0.214	0.511	.010	30	view →
LUAD	OS	Tertile	All	0.881	0.797	.019	27	view →
LIHC	DFS	Tertile	II,III,IV	0.119	0.431	.001	27	view →
CHOL	DFS	Tertile	All	0.858	0.315	.017	21	view →
KIRC	DFS	Tertile	IV	0.241	0.618	.006	18	view →
SKCM	DFS	Quartile	III,IV	0.410	0.744	.001	18	view →
PAAD	OS	Tertile	All	0.578	0.313	.016	18	view →
TGCT	DFS	Tertile	II,III,IV	0.526	0.951	.011	18	view →
THYM	OS	Tertile	All	1.000	0.792	.015	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MIR6806–READ (DFS)

Open the READ breakdown →